CANESPOR

This brand name is authorized in Croatia, Finland, Ireland, Poland, Romania, South Africa.

Active ingredients

The drug CANESPOR contains one active pharmaceutical ingredient (API):

1	Bifonazole UNII QYJ305Z91O - BIFONAZOLE
	Bifonazole is an imidazole derivative with a broad antimycotic spectrum, which includes dermatophytes, yeasts, moulds and other fungi such as Malassezia furfur. It is also effective against Corynebacterium minutissimum.
	Read more about Bifonazole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CANESPOR Cream	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D01AC10	Bifonazole	D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives
Discover more medicines within D01AC10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FI	Lääkealan turvallisuus- ja kehittämiskeskus	570210
HR	Agencija za lijekove i medicinske proizvode	HR-H-662982508
PL	Rejestru Produktów Leczniczych	100045005, 100349700, 100350665, 100364615, 100366206, 100434770
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W55195002, W55196002, W55196003
ZA	Health Products Regulatory Authority	R/13.9.2/203, R/13.9.2/204